FRÉSARD, I.; BRIDEVAUX, P.; JANSSENS, J. Adverse effects and adherence to treatment of rifampicin 4 months vs isoniazid 6 months for latent tuberculosis. Swiss Medical Weekly, [S. l.], v. 141, n. 3334, p. w13240, 2011. DOI: 10.4414/smw.2011.13240. Disponível em: https://smw.ch/index.php/smw/article/view/1333. Acesso em: 28 mar. 2024.